Doxorubicin-SMCC CAS:400647-59-8 is an innovative Doxorubicin derivative featuring a maleimide functional group. This unique structure enables efficient conjugation with thiol-containing molecules, expanding its applicability and enhancing its therapeutic potential.
Introduction to the application:
In pharmaceutical research and development, Doxorubicin-SMCC serves as a versatile building block for the design of targeted drug delivery systems. Its maleimide attachment facilitates conjugation with thiol-containing molecules, such as antibodies or peptides, forming a range of bioconjugates with potential applications in cancer therapy and other diseases. This innovative Doxorubicin derivative is contributing to the development of safer and more effective therapeutic approaches.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
